Education
About Us
Working with TipRanks
Follow Us
3SBio (HK:1530)
:1530
1530 Stock Chart & Stats
HK$29.18
-HK$0.07(-1.20%)
At close: 4:00 PM EST
HK$29.18
-HK$0.07(-1.20%)
Day’s Range― - ―
52-Week RangeHK$5.47 - HK$36.80
Previous CloseN/A
Volume7.16M
Average Volume (3M)31.77M
Market Cap
$72.78B
Enterprise ValueHK$55.53B
Total Cash (Recent Filing)$6.46B
Total Debt (Recent Filing)$1.87B
Price to Earnings (P/E)28.0
Beta0.91
Next Earnings
Mar 31, 2026EPS Estimate
3.87Last Dividend Ex-Date
Jul 21, 2025Dividend Yield0.86%
Share Statistics
EPS (TTM)0.61
Shares Outstanding2,432,594,000
10 Day Avg. Volume25,859,985
30 Day Avg. Volume31,767,927
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)0.91
Price to Sales (P/S)1.54
P/FCF Ratio6.27
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue6.12
Enterprise Value/Gross Profit7.17
Enterprise Value/Ebitda20.64
Forecast
1Y Price Target
$38.64Price Target Upside32.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Clinical DevelopmentsPfizer is expected to aggressively advance 707's global clinical development, which could be a key catalyst for 3SBio's earnings upside.
Stock Performance3SBio's share price rose 18%, outperforming the Hang Seng Healthcare Index.
Strategic Alliances3SBio is reiterated as a preferred pick in the mid-cap Pharma space due to its strategic alliance with Pfizer.
Bears Say
3SBio News
1530 FAQ
What was 3SBio’s price range in the past 12 months?
3SBio lowest stock price was HK$5.47 and its highest was HK$36.80 in the past 12 months.
What is 3SBio’s market cap?
3SBio’s market cap is $72.78B.
When is 3SBio’s upcoming earnings report date?
3SBio’s upcoming earnings report date is Mar 31, 2026 which is in 138 days.
How were 3SBio’s earnings last quarter?
3SBio released its earnings results on Aug 29, 2025. The company reported HK$0.612 earnings per share for the quarter, the consensus estimate of HK$0.612 by HK$0.
Is 3SBio overvalued?
According to Wall Street analysts 3SBio’s price is currently Undervalued.
Does 3SBio pay dividends?
3SBio pays a Annually dividend of HK$0.25 which represents an annual dividend yield of 0.86%. See more information on 3SBio dividends here
What is 3SBio’s EPS estimate?
3SBio’s EPS estimate is 3.87.
How many shares outstanding does 3SBio have?
3SBio has 2,432,594,000 shares outstanding.
What happened to 3SBio’s price movement after its last earnings report?
3SBio reported an EPS of HK$0.612 in its last earnings report, expectations of HK$0.612. Following the earnings report the stock price went up 5.499%.
Which hedge fund is a major shareholder of 3SBio?
Currently, no hedge funds are holding shares in HK:1530
3SBio Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
324.96%
12-Months-Change
Fundamentals
Return on Equity
15.34%
Trailing 12-Months
Asset Growth
0.91%
Trailing 12-Months
Company Description
3SBio
3SBio Inc. is a leading biotechnology company based in China that specializes in the research, development, manufacture, and commercialization of biopharmaceuticals. The company primarily focuses on therapeutic proteins, including recombinant human erythropoietin (rhEPO) for treating anemia, and other products targeting hematology, oncology, and autoimmune diseases. 3SBio plays a significant role in the Chinese biopharmaceutical market and is known for its innovative approach to drug development.
1530 Stock 12 Month Forecast
Average Price Target
HK$38.64
▲(32.44% Upside)
Technical Analysis
Sino Biopharmaceutical
―
Innovent Biologics
―
Wuxi Biologics (Cayman)
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Shanghai Henlius Biotech, Inc. Class H
―
Options Prices
Currently, No data available
---